|Bid||132.58 x 1200|
|Ask||132.82 x 800|
|Day's Range||128.10 - 133.67|
|52 Week Range||15.12 - 133.67|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 06, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||102.36|
The three that top my list for the month of August are REPAY Holdings (NASDAQ: RPAY), Ontrak (NASDAQ: OTRK), and Limelight Networks (NASDAQ: LLNW). E-commerce and digital payment methods are rising thanks to a massive migration to the internet. According to REPAY, which focuses on these markets, B2B and loan repayment transactions use cards less than half the time.
Check out the companies in that sector that have tremendous growth potential, especially those with stocks that are already soaring. Here are three healthcare stocks that could very well make you rich. The company is an innovative leader in a hot area of healthcare.
Livongo Health (LVGO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
This has put some serious pep into the growth outlook for cloud computing. AWS' growth rate is about twice that of Amazon's traditional e-commerce operations, and it generates substantially juicier margins than retail or ad-based revenue.
What happened Shares of Livongo Health (NASDAQ: LVGO) rose sharply on Wednesday and are up by 9.9% as of 11:35 a.m. EDT today, despite the company not reporting any news that served as a catalyst for its stock price jumping.
Many investors are also licking their wounds with the recent market volatility, but some fortunate souls are having a great year with their stock picks. Etsy (NASDAQ: ETSY), Camping World (NYSE: CWH), and Livongo Health (NASDAQ: LVGO) are some of the bear-busting stocks that have more than doubled in 2020. The stay-at-home phase of this pandemic awakened the artist and eventually the entrepreneur in a lot of us, and Etsy is cashing in on the process.
Livongo Health (NASDAQ: LVGO) could be such a stock. Let's look at what the company does and why I believe it could generate life-changing returns in more ways than one. The company's connected devices help those with chronic health issues better manage their conditions, thereby lowering the cost of their overall healthcare.
The stock market has been a bit of a roller coaster of late. During the first quarter, the market crashed hard, but it has been recovering nicely since late March. However, some stocks have performed consistently well throughout, including Livongo Health (NASDAQ: LVGO) and Spotify (NYSE: SPOT).
If you've got $10,000 to invest and can stomach high levels of volatility, here are three growth stocks that could make you a fast fortune. The company focuses on two related markets -- content delivery networks (CDNs) and edge computing (processing at the edge of the cloud where organizations' networks connect to the cloud). The end goal for both CDNs and edge computing is to accelerate the speed users can access information over the internet.
The coronavirus disease 2019 (COVID-19) pandemic has led to unprecedented stock market volatility, with the benchmark S&P 500 losing 34% of its value in less than five weeks during the first quarter, then delivering its best quarterly performance in 22 years during the second quarter. Since every stock market correction in history (prior to COVID-19) has eventually been erased by a bull market rally, it's only logical to assume that a new bull market will push equities higher. The best part about investing in the stock market is you don't need to have Warren Buffett's wallet if you want to succeed.
If I said, name a technology-driven virtual healthcare platform growing revenue at a triple-digit rate, you'd say Livongo Health (NASDAQ: LVGO), right? This data-driven behavioral healthcare technologist's stock has doubled this year and is forecasting even faster revenue growth than Livongo. Like Livongo, Ontrak partners with employers and healthcare plans to find, treat, and support those with behavioral health conditions, eventually delivering medical expense savings upwards of 50%.
If you missed out on the last stock market correction, don't worry the next one is always right around the corner. This telehealth service provider was expanding at an impressive pace before a pandemic forced physicians to keep in-person interactions to a minimum. In 2019 Teladoc Health facilitated 57% more telehealth visits than during 2018.
Livongo Health (NASDAQ: LVGO) reported Q1 sales of $68.82 million. Earnings fell to a loss of $5.57 million, resulting in a 90.75% decrease from last quarter. Livongo Health collected $50.36 million in revenue during Q4, but reported earnings showed a $5.57 million loss.What Is Return On Capital Employed? Changes in earnings and sales indicate shifts in Livongo Health's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed in a business. Generally, a higher ROCE suggests successful growth in a company and is a sign of higher earnings per share for shareholders in the future. In Q1, Livongo Health posted an ROCE of -0.13%.It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.View more earnings on LVGOReturn on Capital Employed is an important measurement of efficiency and a useful tool when comparing companies that operate in the same industry. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders.In Livongo Health's case, the ROCE ratio shows the amount of assets may not be helping the company achieve higher returns. Investors may take this into account before making any long-term financial decisions.Q1 Earnings Livongo Health reported Q1 earnings per share at $0.03/share against analyst predictions of $-0.04/share.See more from Benzinga * Benzinga's Top Upgrades, Downgrades For July 15, 2020 * Stocks That Hit 52-Week Highs On Monday * Stocks That Hit 52-Week Highs On Friday(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
This high-flying healthcare stock has more than quadrupled year-to-date. Have investors who didn't buy earlier missed out on an opportunity to profit?
There's encouraging vaccine news these days, but your portfolio better be ready for another potential spike in COVID-19 cases.
(Bloomberg) -- Livongo Health Inc. may focus on chronic conditions like diabetes and high blood pressure, but it’s really “a tech company in healthcare clothing,” according to RBC Capital Markets.One year since its public debut, Livongo is fetching comparisons to software-as-a-service names like Zoom Video Communications Inc. and Crowdstrike Holdings Inc. Analyst Sean Dodge said the digital health company is increasingly being valued as a tech company, and it’s warranted given its significant market potential, blistering revenue growth and ability to scale.“From a financial model standpoint, Livongo’s characteristics aren’t all that different,” Dodge said in an interview.Livongo shares have risen 270% since the company went public in July 2019. Most of that advance has taken place since March amid strong revenue and demand for remote patient monitoring services during the pandemic. The market value now exceeds $10 billion.Livongo helps members manage diabetes and prediabetes, high blood pressure, weight and behavioral health. The company sells its services to clients like health plans and self-insured employers, who then cover the cost for their staff to participate.The platform is powered by an engine that aggregates personal data like weight or blood sugar and then interprets them to deliver personalized “health nudges” to users. The company also offers 24/7 human coaching support. Livongo members can receive updates on Apple, Fitbit and Samsung smartwatches, and the company has collaborated with Amazon.com Inc. on an Alexa feature that complies with federal laws on health privacy. Chief Executive Officer Zane Burke said Livongo straddles the line between identifying as a health care company or a tech company.“We’re much more of a tech SaaS business model that understands health care very well,” Burke said in an interview.Locating the company’s headquarters in Alphabet Inc.’s home of Mountain View, California, was no accident. Setting up shop in Silicon Valley “was very purposeful in terms of having the right developer mentality for a consumer application,” Burke said.RBC’s Dodge said he’s received a lot of phone calls from investors to discuss the stock, and there’s been a big increase in the proportion of tech specialists as opposed to those focused on health care. Livongo has several tech-like attributes that cause it to be valued more like a tech company, he said.Livongo shares trade around 20 times estimated sales for 2021, similar to Crowdstrike. Zoom’s valuation is nearly 30 times estimated sales for the fiscal year ending January 2022, according to data compiled by Bloomberg.Benchmark Co. analyst Bill Sutherland said that while Covid-19 has been a tailwind for Livongo so far, higher permanent unemployment could pressure client growth and increase member churn. Burke says the coronavirus has accelerated the transition to a consumer-directed virtual care system.Dodge estimates Livongo’s total addressable market is about $50 billion, with $28 billion attributable to diabetes, $18.5 billion to high blood pressure and the balance to behavioral health.That has attracted competition. Closely held peers, like Glooko Inc. and Omada Health Inc., have likely also been growing rapidly and are closer to achieving the size and scale they need to go public, according to Dodge. Heath insurer UnitedHealth Group Inc. launched a digital service for type 2 diabetes earlier this week.Livongo is also attracting more short bets. About 22% of shares available for trading are currently sold short, according to data compiled by financial analytics firm S3 Partners. That’s up from around 10% at the beginning of June.All but one of the 17 analysts tracked by Bloomberg has a buy rating on the stock, though their average price target is about 5% below where the shares are trading. Goldman Sachs downgraded Livongo to neutral earlier this month, saying growth appeared priced in.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
It's clear that large swaths of the economy have become redundant in this new digital era, and the future favors more nimble and technology-driven enterprise like never before. Three that are worth a look right now are Livongo Health (NASDAQ: LVGO), Universal Display (NASDAQ: OLED), and StoneCo (NASDAQ: STNE).
What happened Shares of Livongo Health (NASDAQ: LVGO) were sliding 6.5% lower as of 11:10 a.m. EDT on Thursday. The digital health-management company didn't announce any news that would cause its stock to fall.
NEW YORK, July 16, 2020 -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at Veeva.